Nurix Therapeutics (NRIX) Receivables - Other: 2020-2025
Historic Receivables - Other for Nurix Therapeutics (NRIX) over the last 4 years, with Aug 2025 value amounting to $1.7 million.
- Nurix Therapeutics' Receivables - Other rose 112.50% to $1.7 million in Q3 2025 from the same period last year, while for Aug 2025 it was $1.7 million, marking a year-over-year increase of 112.50%. This contributed to the annual value of $5.0 million for FY2024, which is 25.00% up from last year.
- Per Nurix Therapeutics' latest filing, its Receivables - Other stood at $1.7 million for Q3 2025, which was down 0.00% from $1.7 million recorded in Q2 2025.
- In the past 5 years, Nurix Therapeutics' Receivables - Other registered a high of $7.0 million during Q1 2025, and its lowest value of $600,000 during Q2 2024.
- In the last 3 years, Nurix Therapeutics' Receivables - Other had a median value of $2.0 million in 2024 and averaged $3.2 million.
- In the last 5 years, Nurix Therapeutics' Receivables - Other tumbled by 88.00% in 2021 and then surged by 300.00% in 2023.
- Over the past 5 years, Nurix Therapeutics' Receivables - Other (Quarterly) stood at $900,000 in 2021, then increased by 11.11% to $1.0 million in 2022, then surged by 300.00% to $4.0 million in 2023, then increased by 25.00% to $5.0 million in 2024, then soared by 112.50% to $1.7 million in 2025.
- Its Receivables - Other stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $7.0 million for Q1 2025.